Inventors:
Dennis J. Thiele - Chapel Hill NC, US
Daniel W. Neef - Durham NC, US
Jose S. Mendoza - Chapel Hill NC, US
Assignee:
DUKE UNIVERSITY - Durham NC
International Classification:
A61K 31/55
C07D 231/38
A61K 31/415
C07D 277/46
A61K 31/426
C07D 239/80
A61K 31/517
C07D 271/07
A61K 31/4245
C07D 409/04
A61K 31/4155
C07D 277/60
A61K 31/428
C07D 405/14
C07D 413/12
C07C 211/27
A61K 31/137
C07D 401/12
C07D 295/135
A61K 31/495
A61P 25/16
A61P 25/28
A61P 9/00
A61P 27/02
A61P 17/02
US Classification:
51421704, 5483725, 514407, 548195, 514371, 544286, 5142663, 548133, 514364, 5483657, 548150, 514366, 544284, 51426621, 564367, 514649, 540597, 544392, 51425503
Abstract:
The present invention relates to HSF activating compounds, methods for their discovery, and their research and therapeutic uses, as well as pharmaceutically acceptable salts, solvates, chelates, non-covalent complexes, prodrugs, mixtures (including both R and S enantiomeric forms and racemic mixtures thereof), and pharmaceutical Formulations thereof. In particular, the present invention provides compounds capable of facilitating HSF1 homotrimerization, and methods of using such compounds as therapeutic agents to treat a number of conditions associated with irregular HSF1 activity.